Acquired in-process research and development
InvestingJohnson & Johnson Acquired in-process research and development decreased by 95.5% to $16.00M in Q3 2025 compared to the prior quarter.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityVolatile
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
High spending indicates a strong commitment to pipeline growth, though it carries significant execution and regulatory risk.
Detailed definition
This represents the cash outflow for the acquisition of in-process research and development projects from other entities...
Peer comparison
High in the pharmaceutical industry where external innovation is a primary driver of long-term revenue.
Metric ID:
cf_acquired_ipr_dHistorical Data
13 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $117.50M | $117.50M | $117.50M | $117.50M | $0.00 | $0.00 | $14.00M | $355.00M | $16.00M |
| QoQ Change | — | — | — | — | — | +0.0% | +0.0% | +0.0% | -100.0% | — | — | >999% | -95.5% |
| YoY Change | — | — | — | — | — | — | — | — | -100.0% | -100.0% | — | — | — |
Range$0.00 – $355.00M
Avg YoY Growth-100.0%
Median YoY Growth-100.0%
Acquired in-process research and development at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's acquired in-process research and development?
- Johnson & Johnson (JNJ) reported acquired in-process research and development of $16.00M in Q3 2025.
- What does acquired in-process research and development mean?
- Cash spent to acquire research projects or drug candidates currently in development.